EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Benchmarking of an Intervention Aiming at the Micro-Elimination of Hepatitis C in Vulnerable Populations in Perpignan, France, to Inform Scale-Up and Elimination on the French Territory

Gordana Avramovic iD, Laura O'Doherty, Tina McHugh, Andre Jean Remy iD, Arnaud Happiette, Hakim Bouchkira, Philippe Murat, Olivier Scemama, Adrien Esclade, Maria Isabel Farfan Camacho, Walter Cullen, John S Lambert

Viruses · 2024

DOI: 10.3390/v16101645 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Viruses, 2024. Verfasst von Gordana Avramovic und 11 weiteren Autor:innen. Beteiligte Einrichtung: Mater Misericordiae University Hospital, 44 Eccles St, D07 R2WY Dublin, Ireland. Hauptthemen laut MEDLINE: Benchmarking, Hepacivirus, Hepatitis C, Vulnerable Populations. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 30 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Directorate General for Reform Support, European Union, European Commission, French Ministry of Health (MoH).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Hepatitis C virus (HCV) is an important cause of chronic liver disease. Among at-risk populations, access to care is challenging. The French Ministry of Health has supported a seek-and-treat pilot intervention aiming at micro-elimination in Perpignan, France, to inform scale-up of elimination efforts across the whole territory. University College Dublin (UCD) led a successful EU funded project, called HepCare, focusing on the micro-elimination of HCV. UCD was contracted to evaluate and benchmark the Perpignan results against results from HepCare. Using mixed-method approaches including qualitative interviews with patients, a focus group with healthcare professionals, and quantitative analyses of the cascade of care against results obtained at other European sites, we analyse the acceptability, reproducibility, replicability, and effectiveness of the Perpignan intervention. A total of 960 participants were recruited in the Perpignan area. HCV antibody test results were obtained for 928 (96.6%), of which 150 (15.6%) were antibody-positive. Of the antibody-positive participants, 68 (45.3%) tested positive for HCV-RNA, 141 (94%) were linked to care, and of the HCV-RNA-positive participants, 60 (88%) started treatment. Of those who underwent treatment, 34 (56.7%) completed treatment and achieved a sustained viral response (SVR) at dataset closure, 18 (30%) were still in treatment, 5 (8.3%) defaulted from treatment, and 3 (5%) had a virologic failure or died. The intervention in Perpignan was acceptable to patients, but had limitations in effectiveness, as shown in comparisons with HepCare results. To engage harder-to-reach cohorts in France, future models of care in the territory should incorporate peer support.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

BenchmarkingHepacivirusHepatitis CVulnerable PopulationsHumansMaleFemaleFranceMiddle AgedAdultDisease EradicationAgedHepatitis C, ChronicYoung AdultAntiviral Agents

Stichwörter der Autor:innen

HCV eliminationPWIDbenchmarkhepatitis Cintegrated carepeople who inject drugssystems of carevulnerable populations

Substanzen

Antiviral Agents

Autor:innen und Institutionen

  • Mater Misericordiae University Hospital, 44 Eccles St, D07 R2WY Dublin, Ireland.
  • Catherine McAuley Centre, University College Dublin, 21 Nelson St, D07 A8NN Dublin, Ireland.
  • Centre Hospitalier de Perpignan-20 Avenue du Languedoc, 66046 Perpignam, France.
  • Ministère de la Santé et de la Prévention, 14, Avenue Duquesne, 75007 Paris, France.
  • European Commission, Directorate-General for Structural Reform Support, CHARL 9/100, B-1049 Brussels, Belgium.

ORCID-Profile: Gordana Avramovic, Andre Jean Remy

Förderung

  • Directorate General for Reform Support, European Union
  • European Commission
  • French Ministry of Health (MoH)

Zitieren

APA

Avramovic, G., O'Doherty, L., McHugh, T., Remy, A. J., Happiette, A., Bouchkira, H., Murat, P., Scemama, O., Esclade, A., Farfan Camacho, M. I., Cullen, W., & Lambert, J. S. (2024). Benchmarking of an Intervention Aiming at the Micro-Elimination of Hepatitis C in Vulnerable Populations in Perpignan, France, to Inform Scale-Up and Elimination on the French Territory. Viruses. https://doi.org/10.3390/v16101645

Vancouver

Avramovic G, O'Doherty L, McHugh T, Remy AJ, Happiette A, Bouchkira H, et al. Benchmarking of an Intervention Aiming at the Micro-Elimination of Hepatitis C in Vulnerable Populations in Perpignan, France, to Inform Scale-Up and Elimination on the French Territory. Viruses. 2024. doi:10.3390/v16101645

BibTeX
@article{Avramovic2024,
  author = {Avramovic, Gordana and O'Doherty, Laura and McHugh, Tina and Remy, Andre Jean and Happiette, Arnaud and Bouchkira, Hakim and Murat, Philippe and Scemama, Olivier and Esclade, Adrien and Farfan Camacho, Maria Isabel and Cullen, Walter and Lambert, John S},
  title = {Benchmarking of an Intervention Aiming at the Micro-Elimination of Hepatitis C in Vulnerable Populations in Perpignan, France, to Inform Scale-Up and Elimination on the French Territory},
  journal = {Viruses},
  year = {2024},
  doi = {10.3390/v16101645}
}
Kostenlos starten →